SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001214659-13-001633
Filing Date
2013-03-26
Accepted
2013-03-26 16:32:57
Documents
21
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012 t32213110k.htm 10-K 2301292
2 EXHIBIT 3.2 ex3_2.htm EX-3.2 11382
3 EXHIBIT 10.34 ex10_34.htm EX-10.34 5616
4 EXHIBIT 10.35 ex10_35.htm EX-10.35 30076
5 EXHIBIT 23.1 ex23_1.htm EX-23.1 4217
6 EXHIBIT 31.1 ex31_1.htm EX-31.1 15352
7 EXHIBIT 31.2 ex31_2.htm EX-31.2 15595
8 EXHIBIT 32.1 ex32_1.htm EX-32.1 6482
9 EXHIBIT 32.2 ex32_2.htm EX-32.2 7468
16 img1.jpg GRAPHIC 44171
17 img2.jpg GRAPHIC 46072
18 img3.jpg GRAPHIC 54656
19 img4.jpg GRAPHIC 63992
20 img5.jpg GRAPHIC 12575
21 img6.jpg GRAPHIC 47170
  Complete submission text file 0001214659-13-001633.txt   10753692

Data Files

Seq Description Document Type Size
10 EXHIBIT 101.INS anth-20121231.xml EX-101.INS 1538625
11 EXHIBIT 101.SCH anth-20121231.xsd EX-101.SCH 70381
12 EXHIBIT 101.CAL anth-20121231_cal.xml EX-101.CAL 65491
13 EXHIBIT 101.DEF anth-20121231_def.xml EX-101.DEF 232638
14 EXHIBIT 101.LAB anth-20121231_lab.xml EX-101.LAB 908228
15 EXHIBIT 101.PRE anth-20121231_pre.xml EX-101.PRE 423084
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34637 | Film No.: 13717223
SIC: 2834 Pharmaceutical Preparations